Montelin, Myca .

HRN: 24-08-13  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
CEFUROXIME 750MG (VIAL)
11/12/2023
11/19/2023
IV
240mg
Q8H
Benign Febrile Seizure; PCAP B
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: